These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22777686)

  • 41. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
    Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
    J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of formulation on the stability and aerosol performance of a nebulized antibody.
    Respaud R; Marchand D; Parent C; Pelat T; Thullier P; Tournamille JF; Viaud-Massuard MC; Diot P; Si-Tahar M; Vecellio L; Heuzé-Vourc'h N
    MAbs; 2014; 6(5):1347-55. PubMed ID: 25517319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of sugar molecules on the viscosity of high concentration monoclonal antibody solutions.
    He F; Woods CE; Litowski JR; Roschen LA; Gadgil HS; Razinkov VI; Kerwin BA
    Pharm Res; 2011 Jul; 28(7):1552-60. PubMed ID: 21573867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subcutaneous delivery of monoclonal antibodies: How do we get there?
    Viola M; Sequeira J; Seiça R; Veiga F; Serra J; Santos AC; Ribeiro AJ
    J Control Release; 2018 Sep; 286():301-314. PubMed ID: 30077735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
    Gikanga B; Chen Y; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.
    Yadav S; Shire SJ; Kalonia DS
    J Pharm Sci; 2010 Dec; 99(12):4812-29. PubMed ID: 20821382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
    Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing Physicochemical Stability of Monoclonal Antibodies in a Simulated Subcutaneous Environment.
    Jogdeo CM; Bhattacharya DS; Lin V; Kolhe P; Badkar A
    J Pharm Sci; 2024 Jul; 113(7):1854-1864. PubMed ID: 38341129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viscosity behavior of high-concentration protein mixtures.
    Galush WJ; Le LN; Moore JM
    J Pharm Sci; 2012 Mar; 101(3):1012-20. PubMed ID: 22170353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.
    Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
    Eur J Pharm Biopharm; 2017 Nov; 120():1-8. PubMed ID: 28754261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.
    Kennel SJ; Woodward JD; Rondinone AJ; Wall J; Huang Y; Mirzadeh S
    Nucl Med Biol; 2008 May; 35(4):501-14. PubMed ID: 18482688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
    Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
    Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluation.
    Wegmann M; Parola L; Bertera FM; Taira CA; Cagel M; Buontempo F; Bernabeu E; Höcht C; Chiappetta DA; Moretton MA
    J Pharm Pharmacol; 2017 May; 69(5):544-553. PubMed ID: 27431770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of stability and dissolution of realgar nano-particles using solid dispersion technology].
    Guo T; Shi F; Yang G; Feng NP
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2782-7. PubMed ID: 24380298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions.
    Wu Z; Tucker IG; Razzak M; McSporran K; Medlicott NJ
    J Pharm Pharmacol; 2010 Jul; 62(7):873-82. PubMed ID: 20636875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process.
    Salmaso S; Elvassore N; Bertucco A; Caliceti P
    J Pharm Sci; 2009 Feb; 98(2):640-50. PubMed ID: 18484622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Hierarchical Cluster Formation on the Viscosity of Concentrated Monoclonal Antibody Formulations Studied by Neutron Scattering.
    Godfrin PD; Zarraga IE; Zarzar J; Porcar L; Falus P; Wagner NJ; Liu Y
    J Phys Chem B; 2016 Jan; 120(2):278-91. PubMed ID: 26707135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations.
    Buck PM; Chaudhri A; Kumar S; Singh SK
    Mol Pharm; 2015 Jan; 12(1):127-39. PubMed ID: 25383990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.